Oxeco Plc to Purchase Tissue Regenix Ltd in £12M (US$17.53M) Share-Based Reverse Takeover
6/7/2010 8:58:57 AM
Genengnews -- Oxeco has conditionally agreed to acquire regenerative therapies firm Tissue Regenix for £12 million, or about $17.53 million, in shares. Oxeco, in addition, reported that it has conditionally raised £4.5 million, or approximately $6.57 million, before expenses by way of a placing. It is expected to bolster the newly combined firm’s working capital to about £7.4 million, or roughly $10.81 million) net.
comments powered by